Pancreatic Cancer News -- ScienceDaily //www.koonmotors.com/news/health_medicine/pancreatic_cancer/ Read about the latest medical research concerning pancreatic cancer and other disorders of the pancreas. Consider new treatment options. en-us Wed, 06 Sep 2023 14:45:38 EDT Wed, 06 Sep 2023 14:45:38 EDT 60 Pancreatic Cancer News -- ScienceDaily //www.koonmotors.com/images/scidaily-logo-rss.png//www.koonmotors.com/news/health_medicine/pancreatic_cancer/ For more science news, visit ScienceDaily. 'Super-enhancer' super-charges pancreatic tumor growth //www.koonmotors.com/releases/2023/09/230906112428.htm Scientists identified new set of molecules that drive the growth of human pancreatic cancer cell lines, explaining how genetic mutations can activate genetic 'super-enhancers' that promote out-of-control pancreatic cancer growth. They show the efficacy of an experimental drug that targets a super-enhancer related protein, demonstrating the promise of therapeutics that block the effects of super-enhancers. Wed, 06 Sep 2023 11:24:28 EDT //www.koonmotors.com/releases/2023/09/230906112428.htm Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer //www.koonmotors.com/releases/2023/08/230829125932.htm Early laboratory results in mice show the drug PXS-5505 increases survival when combined with chemotherapy in the treatment of pancreatic ductal adenocarcinomas. Tue, 29 Aug 2023 12:59:32 EDT //www.koonmotors.com/releases/2023/08/230829125932.htm Enhanced tumor modeling using Laponite bioinks for 3D bioprinting //www.koonmotors.com/releases/2023/08/230803112928.htm Scientists have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinted tumor models. These capabilities are enabled by the addition of Laponite, highly charged, disk-shaped nanoparticles which enhance and retain the biological signaling that occurs in the tumor microenvironment so that more accurate tumor models can be created for study and anti-tumor drug development. Thu, 03 Aug 2023 11:29:28 EDT //www.koonmotors.com/releases/2023/08/230803112928.htm New research casts doubt on role of fungus in driving pancreatic cancer //www.koonmotors.com/releases/2023/08/230803112355.htm Four years ago, a report that a common species of fungus might fuel pancreatic cancer offered a promising new view of the deadly disease. But in working to validate the finding, researchers have found no such association. Thu, 03 Aug 2023 11:23:55 EDT //www.koonmotors.com/releases/2023/08/230803112355.htm Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers //www.koonmotors.com/releases/2023/07/230717115358.htm Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab, an anti-CD137 agonist antibody treatment, is safe, it increases the amount of cancer-killing immune system T cells in the tumors and it appears effective when given two weeks prior to cancer-removal surgery, according to new research. Mon, 17 Jul 2023 11:53:58 EDT //www.koonmotors.com/releases/2023/07/230717115358.htm One-two punch: Novel drug pairing could beat pancreatic cancer //www.koonmotors.com/releases/2023/06/230628125341.htm Researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial. Wed, 28 Jun 2023 12:53:41 EDT //www.koonmotors.com/releases/2023/06/230628125341.htm Cancer cells use a new fuel in absence of sugar //www.koonmotors.com/releases/2023/05/230518120901.htm Researchers have discovered a new nutrient source that pancreatic cancer cells use to grow. The molecule, uridine, offers insight into both biochemical processes and possible therapeutic pathways. The findings show that cancer cells can adapt when they don't have access to glucose. Thu, 18 May 2023 12:09:01 EDT //www.koonmotors.com/releases/2023/05/230518120901.htm Implantable device shrinks pancreatic tumors //www.koonmotors.com/releases/2023/04/230413154303.htm Nanomedicine researchers have found a way to tame pancreatic cancer -- one of the most aggressive and difficult to treat cancers -- by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice. Thu, 13 Apr 2023 15:43:03 EDT //www.koonmotors.com/releases/2023/04/230413154303.htm Biomarkers show promise for identifying early risk of pancreatic cancer //www.koonmotors.com/releases/2023/03/230317184937.htm A research team has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. Fri, 17 Mar 2023 18:49:37 EDT //www.koonmotors.com/releases/2023/03/230317184937.htm How pancreatic cancer defies treatment //www.koonmotors.com/releases/2023/01/230119133348.htm Researchers describe how pancreatic cancer stem cells leverage a protein in a family of proteins that normally suppress tumors to instead do the opposite, boosting their resistance to conventional treatments and spurring growth. Thu, 19 Jan 2023 13:33:48 EST //www.koonmotors.com/releases/2023/01/230119133348.htm Stress-tolerant cells drive tumor initiation in pancreatic cancer //www.koonmotors.com/releases/2023/01/230116112552.htm 科学家发现一种分子通路关键to the initiation of pancreatic tumors. The findings may inspire new chemotherapeutic drugs targeting early stages of tumor formation and spread. Mon, 16 Jan 2023 11:25:52 EST //www.koonmotors.com/releases/2023/01/230116112552.htm Study discovers triple immunotherapy combination as possible treatment for pancreatic cancer //www.koonmotors.com/releases/2022/12/221230142240.htm Researchers have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor immune microenvironment (TIME) and significantly improved anti-tumor responses in preclinical models of pancreatic cancer. Fri, 30 Dec 2022 14:22:40 EST //www.koonmotors.com/releases/2022/12/221230142240.htm Adjuvant Chemotherapy Improves Overall Survival for Pancreatic Cancer Patients //www.koonmotors.com/releases/2022/12/221208114721.htm A new study showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients. Thu, 08 Dec 2022 11:47:21 EST //www.koonmotors.com/releases/2022/12/221208114721.htm Study shows promise of new anti-KRAS drug for pancreatic cancer //www.koonmotors.com/releases/2022/12/221206105910.htm A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic cancer, researchers showed. Tue, 06 Dec 2022 10:59:10 EST //www.koonmotors.com/releases/2022/12/221206105910.htm New genetic culprit suspected in the onset of pancreatic cancer //www.koonmotors.com/releases/2022/11/221130114525.htm New research points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer. The findings could alter the scientific understanding of this deadly disease and inform the establishment of novel treatments. Wed, 30 Nov 2022 11:45:25 EST //www.koonmotors.com/releases/2022/11/221130114525.htm New insights into the mechanisms causing diabetes //www.koonmotors.com/releases/2022/11/221107114447.htm Researchers show that a molecule called T-cadherin can be secreted in a soluble form. Soluble T-cadherin interacts with pancreatic insulin-producing beta cells via the Notch signaling pathway to promote their proliferation and increase the production of insulin. Recombinant T-cadherin stimulated Notch signaling in isolated mouse pancreatic islets, which contain beta cells, indicating that T-cadherin may have therapeutic potential for diabetes. Mon, 07 Nov 2022 11:44:47 EST //www.koonmotors.com/releases/2022/11/221107114447.htm Cancer deaths continue downward trend in U.S.; Modest improvements in survival for pancreatic cancer //www.koonmotors.com/releases/2022/10/221027170415.htm Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. Thu, 27 Oct 2022 17:04:15 EDT //www.koonmotors.com/releases/2022/10/221027170415.htm Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice //www.koonmotors.com/releases/2022/10/221020201434.htm Biomedical engineers have demonstrated the most effective treatment for pancreatic cancer in mouse models ever recorded. While most mouse trials consider simply halting growth a success, the new treatment completely eliminated tumors in 80% of mice across several model types, including those considered the most difficult to treat. The approach combines traditional chemotherapy drugs with a new method for irradiating the tumor. Thu, 20 Oct 2022 20:14:34 EDT //www.koonmotors.com/releases/2022/10/221020201434.htm Two drugs reverse key pancreatic cancer step in the lab //www.koonmotors.com/releases/2022/10/221019172134.htm Two drugs -- one brand new -- reverse pancreatic cell changes that presage one of the hardest cancers to treat. Tested in cells, the drugs would be a promising early cancer treatment if they work in clinical trials. Wed, 19 Oct 2022 17:21:34 EDT //www.koonmotors.com/releases/2022/10/221019172134.htm Scientists identify link between mitochondria and pancreatic cancer risk //www.koonmotors.com/releases/2022/10/221012163433.htm 我科学家区分特定的基因签名ndicative of mitochondrial reprogramming in tumors that correlates with poor patient outcome. Wed, 12 Oct 2022 16:34:33 EDT //www.koonmotors.com/releases/2022/10/221012163433.htm Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment //www.koonmotors.com/releases/2022/10/221010115335.htm Investigators have examined the microbiome of pancreatic tumors and identified particular microorganisms at single cell resolution that are associated with inflammation and with poor survival. According to the researchers, these microorganisms may be new targets for earlier diagnosis or treatment of pancreatic cancer, which is the fourth leading cause of cancer death for both men and women in the United States. Mon, 10 Oct 2022 11:53:35 EDT //www.koonmotors.com/releases/2022/10/221010115335.htm Researchers find link between immune cells' closest neighbors and survival time in patients with pancreatic cancer //www.koonmotors.com/releases/2022/10/221006141500.htm Researchers have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive. Thu, 06 Oct 2022 14:15:00 EDT //www.koonmotors.com/releases/2022/10/221006141500.htm Genetic test for pancreatic cancer outperforms current guidelines //www.koonmotors.com/releases/2022/10/221005111910.htm A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study. Wed, 05 Oct 2022 11:19:10 EDT //www.koonmotors.com/releases/2022/10/221005111910.htm Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies //www.koonmotors.com/releases/2022/10/221005111902.htm Researchers have found a possible way to overcome barriers that block effective anti-cancer immune responses, thereby opening the potential for more effective immunotherapies. They report the STimulator of INterferon Genes (STING) has the promise of powerfully provoking multiple parts of the immune system and breaking established barriers. Their laboratory findings could have implications for treating solid tumors, including breast and pancreatic cancers. Wed, 05 Oct 2022 11:19:02 EDT //www.koonmotors.com/releases/2022/10/221005111902.htm AI helps detect pancreatic cancer //www.koonmotors.com/releases/2022/09/220913110443.htm An artificial intelligence (AI) tool is highly effective at detecting pancreatic cancer on CT, according to a new study. Tue, 13 Sep 2022 11:04:43 EDT //www.koonmotors.com/releases/2022/09/220913110443.htm Mechanisms at work in progression of pancreatic cysts to pancreatic cancer //www.koonmotors.com/releases/2022/08/220831210044.htm Researchers have outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. The findings could reveal the mechanism of neoplastic progression and provide targets for immunotherapy to inhibit progression or treat invasive disease. Wed, 31 Aug 2022 21:00:44 EDT //www.koonmotors.com/releases/2022/08/220831210044.htm 研究提供了深入了解胰腺癌develops //www.koonmotors.com/releases/2022/08/220822130236.htm A detailed analysis of pancreatic cancer by researchers at Washington University School of Medicine in St. Louis has revealed details of two key transition points in the development of these tumors -- the shift from normal cells to precancerous cells, and the change from precancerous to cancerous cells. Understanding these transitions will help lead to the development of novel therapies. Mon, 22 Aug 2022 13:02:36 EDT //www.koonmotors.com/releases/2022/08/220822130236.htm Potential target for Type 1 diabetes treatment //www.koonmotors.com/releases/2022/07/220722082419.htm Scientists have discovered a pathway to the regeneration of insulin in pancreatic stem cells, a major breakthrough toward new therapies to treat Type 1 and Type 2 diabetes. Using the pancreas stem cells of a type 1 diabetic donor, researchers were able to effectively reactivate them to become insulin-expressing and functionally resemble beta-like cells through the use of a drug approved by the US Food and Drug Administration but not currently licensed for diabetes treatment. Fri, 22 Jul 2022 08:24:19 EDT //www.koonmotors.com/releases/2022/07/220722082419.htm Regular screening of people at high risk for pancreatic cancer pays off //www.koonmotors.com/releases/2022/07/220713114610.htm Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study. Wed, 13 Jul 2022 11:46:10 EDT //www.koonmotors.com/releases/2022/07/220713114610.htm Scientists discover mechanism controlling spread of pancreatic cancer //www.koonmotors.com/releases/2022/06/220629121124.htm Scientists have shown it is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body. These findings show that a protein called GREM1 is key to regulating the type of cells found in pancreatic cancer -- and manipulating its levels can both fuel and reverse the ability of these cells to change into a more aggressive subtype. Researchers hope, in the future, to use this knowledge to find ways to reverse more advanced pancreatic cancer into a less aggressive form, which is easier to treat. Wed, 29 Jun 2022 12:11:24 EDT //www.koonmotors.com/releases/2022/06/220629121124.htm Researchers develop pancreatic beta-cell restoring therapy for treating type 1 diabetes //www.koonmotors.com/releases/2022/06/220614164431.htm Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition according to new data. Tue, 14 Jun 2022 16:44:31 EDT //www.koonmotors.com/releases/2022/06/220614164431.htm Existing cancer therapy in narrow use shows significant activity against other cancers //www.koonmotors.com/releases/2022/06/220609155820.htm A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to a new study. Ivosidenib, or AG-120, is currently used against cancers that have a mutation in the IDH1 gene. However, study results show that Ivosidenib is also effective against unmutated, or 'wild-type' IDH1. The protein coded by the IDH1 gene in cancers helps cancer cells survive in a stressful tumor environment, so any inhibitor medication that could weaken this defense mechanism is considered a promising therapy. Thu, 09 Jun 2022 15:58:20 EDT //www.koonmotors.com/releases/2022/06/220609155820.htm Biomarkers for early detection of cancer //www.koonmotors.com/releases/2022/06/220609131941.htm Successful treatment of cancer frequently depends on early detection. However, many cancers are detected late, often after metastasizing to other sites. New research aims to improve early detection and cancer prevention using advanced biomarkers and radiomics. Thu, 09 Jun 2022 13:19:41 EDT //www.koonmotors.com/releases/2022/06/220609131941.htm High fat diet, unregulated athletic exercise endurance enhancers linked to risk of pancreatic cancer //www.koonmotors.com/releases/2022/06/220601170205.htm A study suggests that substances touted to improve athletic performance can activate a receptor that accelerates the progression of pre-cancerous lesions to pancreatic cancer in mice. Wed, 01 Jun 2022 17:02:05 EDT //www.koonmotors.com/releases/2022/06/220601170205.htm Breaking the shield that protects pancreatic cancer from immunotherapy //www.koonmotors.com/releases/2022/05/220505143826.htm Scar-like细胞构成了相当大的一部分malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study suggests. The findings could offer a new strategy to fight pancreatic cancer, a deadly disease for which no truly effective treatments exist. Thu, 05 May 2022 14:38:26 EDT //www.koonmotors.com/releases/2022/05/220505143826.htm Research pushes closer to new therapy for pancreatic cancer //www.koonmotors.com/releases/2022/05/220505143759.htm Nanotechnology research has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies. Thu, 05 May 2022 14:37:59 EDT //www.koonmotors.com/releases/2022/05/220505143759.htm Stem cell therapy protects against the side effects of cancer drugs //www.koonmotors.com/releases/2022/05/220505085613.htm Researchers report that the therapeutic use of mesenchymal stem cells is effective at suppressing the onset of diabetes induced by immune checkpoint inhibitors used to treat cancer. Mesenchymal stem cells therefore have potential as a new type of adjuvant cell therapy. Thu, 05 May 2022 08:56:13 EDT //www.koonmotors.com/releases/2022/05/220505085613.htm AI may detect earliest signs of pancreatic cancer //www.koonmotors.com/releases/2022/04/220426153718.htm An artificial intelligence (AI) tool can accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. The findings may help prevent death through early detection of one of the most challenging cancers to treat. Tue, 26 Apr 2022 15:37:18 EDT //www.koonmotors.com/releases/2022/04/220426153718.htm Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method //www.koonmotors.com/releases/2022/04/220422094328.htm Pancreatic cancer has a significantly poor prognosis; therefore, the development of effective treatments is an unmet clinical need. The major drawback in this field was the lack of useful model animals, which delayed the establishment of markers for early diagnosis and therapeutic options. The research group established an effective carcinogenesis method with wild-type rats by selectively introducing oncogenes into the pancreas, using the pancreas-targeted hydrodynamic gene delivery method that has been developed by the group. Fri, 22 Apr 2022 09:43:28 EDT //www.koonmotors.com/releases/2022/04/220422094328.htm The protein that keeps the pancreas from digesting itself //www.koonmotors.com/releases/2022/04/220421100132.htm Scientists report that a protein known as estrogen-related receptor gamma is critical for preventing pancreatic auto-digestion in mice. Moreover, they discovered that people with pancreatitis have lower levels of this protein in cells affected by this inflammation. Thu, 21 Apr 2022 10:01:32 EDT //www.koonmotors.com/releases/2022/04/220421100132.htm The origins and ID of pancreatic endocrine cells //www.koonmotors.com/releases/2022/04/220419092324.htm Scientists show that endocrine stem cells in the pancreas disappear after birth, and detail the genetic identity of the different types of pancreatic hormone-producing cells. Tue, 19 Apr 2022 09:23:24 EDT //www.koonmotors.com/releases/2022/04/220419092324.htm Artificial intelligence may improve diabetes diagnosis, study shows //www.koonmotors.com/releases/2022/04/220405102823.htm Using a fully-automated artificial intelligence (AI) deep learning model, researchers were able to identify early signs of type 2 diabetes on abdominal CT scans, according to a new study. Tue, 05 Apr 2022 10:28:23 EDT //www.koonmotors.com/releases/2022/04/220405102823.htm Distinct classes of fibroblasts in tumors play opposing roles, promoting or restraining pancreatic cancer growth //www.koonmotors.com/releases/2022/03/220329114707.htm Researchers discovered that two distinct classes of fibroblast cells accumulate in pancreatic tumors and play opposing roles to promote and restrain pancreatic cancer growth. Appropriately targeting these cells may offer options to improve treatment outcomes. Tue, 29 Mar 2022 11:47:07 EDT //www.koonmotors.com/releases/2022/03/220329114707.htm Novel therapeutic strategy shows promise against pancreatic cancer //www.koonmotors.com/releases/2022/03/220323151658.htm Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%. Wed, 23 Mar 2022 15:16:58 EDT //www.koonmotors.com/releases/2022/03/220323151658.htm Could diet modification make chemotherapy drugs more effective for patients with pancreatic cancer? //www.koonmotors.com/releases/2022/03/220322122830.htm The findings of a new study suggest that a ketogenic diet -- which is low in carbohydrates and protein, but high in fat -- helps to kill pancreatic cancer cells when combined with a triple-drug therapy. In laboratory experiments, the ketogenic diet decreased glucose (sugar) levels in the tumor, suggesting the diet helped starve the cancer. In addition, this diet elevated ketone bodies produced by the liver, which put additional stress on the cancer cells. Tue, 22 Mar 2022 12:28:30 EDT //www.koonmotors.com/releases/2022/03/220322122830.htm Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows //www.koonmotors.com/releases/2022/03/220307113043.htm A new study -- in mice -- suggests that blocking a major inflammatory pathway that is activated in pancreatic cancer makes the tumors sensitive to chemotherapy and a type of immunotherapy that prompts the immune system's T cells to attack the cancer cells. The therapy more than doubled survival in a mouse model of pancreatic cancer. Mon, 07 Mar 2022 11:30:43 EST //www.koonmotors.com/releases/2022/03/220307113043.htm Researchers produce fully functional pancreatic beta cells from stem cells //www.koonmotors.com/releases/2022/03/220303120803.htm Researchers have carried out pioneering efforts to optimize the functionality of pancreatic cells produced from stem cells. In a new study, the group has demonstrated that stem cells can form cells that closely mimic normal pancreatic islets, in terms of both structure and function. Thu, 03 Mar 2022 12:08:03 EST //www.koonmotors.com/releases/2022/03/220303120803.htm Pancreatic cancer: Cellular process suggests path to new treatment options //www.koonmotors.com/releases/2022/02/220224112613.htm Drug resistance is a major obstacle in the treatment of cancers. In an aggressive type of pancreatic cancer, for instance, drug resistance is associated with the suppression of programmed cell death, which results in the uncontrolled growth of cancer cells. Until recently, the process underlying this phenomenon had remained unknown. A team of researchers has now elucidated the way in which different factors interact in order to enable these cancer cells to survive. They were able to show that inhibition of a key protein limits cancer growth. The researchers' findings may herald a new treatment target for aggressive cancers. Thu, 24 Feb 2022 11:26:13 EST //www.koonmotors.com/releases/2022/02/220224112613.htm Pushing past pancreatic tumors’ defenses //www.koonmotors.com/releases/2022/02/220216083000.htm Researchers found that some cancer cells weave a deactivating signal into a protective coat of armor, immobilizing and excluding T cells that would otherwise kill them. This immune deactivation pathway offers a promising new therapeutic approach for pancreatic, breast, and colorectal cancers. Wed, 16 Feb 2022 08:30:00 EST //www.koonmotors.com/releases/2022/02/220216083000.htm Gut bacteria linked to immune suppression in pancreatic cancer //www.koonmotors.com/releases/2022/02/220208113544.htm Researchers have shown how probiotic bacteria in the gut could undermine immunity in pancreatic cancer, pointing toward more personalized cancer treatments. Tue, 08 Feb 2022 11:35:44 EST //www.koonmotors.com/releases/2022/02/220208113544.htm Pancreatic cancer cells feed off hyaluronic acid //www.koonmotors.com/releases/2022/01/220127120154.htm Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study shows that hyaluronic acid also acts as food to the cancer cells. These findings provide insight into how pancreatic cancer cells grow and indicate new possibilities to treat them. Thu, 27 Jan 2022 12:01:54 EST //www.koonmotors.com/releases/2022/01/220127120154.htm Faulty BRCA genes linked to prostate and pancreatic cancers //www.koonmotors.com/releases/2022/01/220125162420.htm Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men. Tue, 25 Jan 2022 16:24:20 EST //www.koonmotors.com/releases/2022/01/220125162420.htm New findings on bacteria that increase risk of pancreatic cancer //www.koonmotors.com/releases/2021/11/211124154110.htm Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumors. Now for the first time, live bacteria from cystic pancreatic lesions that are precursors to pancreatic cancer, have been analyzed by researchers. The study can lead to prophylactic interventions using local antibiotics. Wed, 24 Nov 2021 15:41:10 EST //www.koonmotors.com/releases/2021/11/211124154110.htm Strategy to overcome tumors’ resistance to immunotherapy generates promising clinical trial results //www.koonmotors.com/releases/2021/11/211118203604.htm Immune checkpoint inhibitors strengthen the immune response against cancer cells, but the medications are ineffective against certain tumors. Results from a new clinical trial indicate that adding radiation may overcome this resistance to immune checkpoint inhibitors. Thu, 18 Nov 2021 20:36:04 EST //www.koonmotors.com/releases/2021/11/211118203604.htm New symptoms identified that could help doctors diagnose pancreatic cancer //www.koonmotors.com/releases/2021/11/211108081631.htm Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms -- feeling thirsty and having dark urine. Mon, 08 Nov 2021 08:16:31 EST //www.koonmotors.com/releases/2021/11/211108081631.htm RAS inhibitors for use in fighting more cancers //www.koonmotors.com/releases/2021/11/211104162559.htm New findings help better understand the how one of the most commonly mutated genetic drivers of cancer passes signals that cause the disease. Thu, 04 Nov 2021 16:25:59 EDT //www.koonmotors.com/releases/2021/11/211104162559.htm Experimental drug boosts immunotherapy effectiveness in pancreatic cancer in mice //www.koonmotors.com/releases/2021/11/211104081448.htm An experimental drug enhanced the benefit of an immunotherapy to fight pancreatic cancer in mice by increasing the number of immune cells in the immediate vicinity of the tumor, leading to a reduction in tumor growth, and in some mice, eliminating their cancer. Thu, 04 Nov 2021 08:14:48 EDT //www.koonmotors.com/releases/2021/11/211104081448.htm Uncovering how injury to the pancreas impacts cancer formation //www.koonmotors.com/releases/2021/10/211029103155.htm 开创性的研究显示,腺泡的细胞pancreas form new cell types to mitigate injury but are then susceptible to cancerous mutations. Fri, 29 Oct 2021 10:31:55 EDT //www.koonmotors.com/releases/2021/10/211029103155.htm Cancer costs US more than $156 billion annually, with drugs a leading expense //www.koonmotors.com/releases/2021/10/211006132334.htm Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team researchers. The team also found that medication was the biggest expense and that medication expense for breast, lung, lymphoma and colorectal cancers incurred the most costs. Wed, 06 Oct 2021 13:23:34 EDT //www.koonmotors.com/releases/2021/10/211006132334.htm Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells //www.koonmotors.com/releases/2021/09/210930140715.htm What makes pancreatic cancer so deadly is its covert and quick spread. Now, a 'time machine' has shown a way to reverse the course of cancer before it spreads throughout the pancreas. Thu, 30 Sep 2021 14:07:15 EDT //www.koonmotors.com/releases/2021/09/210930140715.htm